Investor Relations

Corporate Overview

PDS Biotech is a clinical stage biopharmaceutical company with a growing pipeline of cancer immunotherapies and infectious disease vaccines. Our team is committed to developing first-in-class T cell activating immunotherapies to fight against cancer and to provide more rapid and longer-lasting protection against infectious diseases.


noun cells 3844187

3 Proprietary T cell activating platforms
noun pharmacogenomics 4478854

4 Ongoing Phase 2 clinical trials
noun partnership 3317408

With Merck, MD Anderson Cancer Center,
National Cancer Institute and Mayo Clinic

Corporate Presentation

Upcoming Events